Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are reasonably physically active and able to carry out daily activities — scored at a certain level on a standard health performance scale (confirm with trial site)
- People who are able to understand the trial information and are willing to sign a written consent form
- People who are already enrolled in another treatment clinical trial may still be able to join this trial, as the trial site allows this at the treating doctor's discretion
- People who have a confirmed diagnosis of invasive or in-situ breast cancer (cancer that has been verified by laboratory testing of tissue)
- People whose treating doctor has determined that radiation therapy after breast-conserving surgery (surgery that removes the cancer but keeps most of the breast) is the appropriate treatment plan
- People who are female
Who may not be able to join:
- People for whom an MRI scan is not safe or suitable based on a standard MRI safety checklist
- People whose breast tumour or tumour area cannot be clearly seen on CT or MRI scans during radiation treatment planning
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lisa Singer, MD, PhD, University of California, San Francisco
Phone: 877-827-3222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of participants who completed scan
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.